非脱垂子宫经阴道与经腹切除的比较  

Compare VH with TAH for Nonprolapse of the Uterus

作　　者：杨丹[1] 李红[1] 

机构地区：[1]复旦大学附属中山医院妇产科,上海200032

出　　处：《复旦学报（医学版）》2001年第3期257-259,共3页Fudan University Journal of Medical Sciences

摘　　要：目的　对非脱垂的良性子宫疾病全子宫切除的不同方法进行评价 ,以更合理地制定手术方案。方法　非脱垂子宫行阴道全子宫切除 (VH) 15例 ,随机选择同期良性子宫疾病行经腹全子宫切除术 (TAH) 15例 ,采用对照研究方法 ,对一般临床资料、手术、术后恢复、住院日和费用等进行对照分析。结果　VH 2例中转经腹手术 ,成功率 87% ,两组一般临床资料、诊断、子宫大小、麻醉、手术范围、失血量差异无显著性 ,VH术后无伤痛 ,用止痛药仅 2 3% ;TAH 15例均有伤口痛 ,用止痛药 47%。住院日、药费及总费用VH明显少于TAH ,两组差异有显著意义 (P =0 .0 0 2 7、0 .0 44 7、0 .0 16 2 )。结论　对良性子宫疾病全子宫切除VH显示的优势特别适合我国国情 ,大子宫并非手术禁忌 。Purpose: To evaluate the different methods of total hysterectomy for with nonprolapse of the uterus benign disease. Methods: Between Apr 1999 and Apr 2000 15 women underwent vaginal hysterectomy (VH) and 15 women underwent total abdominal hysterectomy (TAH) by randomization. To compare VH with TAH perioperative complication, uterine size, convalesence, hospital stay and cost of drug and duration hospitalization. Results: The VH group was successful in 13 of 15 cases (87%). There were no statistically significant differences in diagnostics, uterine size, operative blood loss. The VH has a significantly reduced length of stay, cost of drug and duration hospitalization compare with the TAH (P = 0.0027, 0.0447, 0.0162). Conclusions: Enlargement of the uterus should no longer be considered a contratindication to VH. The VH of operative indication was established. The VH was applied and promoted in the developing country.

关 键 词：经阴道全子宫切除术 适应证 禁忌证 

分 类 号：R713.42[医药卫生—妇产科学]